Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Brief Report: Incidence of HIV in a Nationwide Cohort Receiving Pre-exposure Prophylaxis for HIV Prevention.

Journal of acquired immune deficiency syndromes (1999) - 15 Dec 2019

Van Epps Puja, Wilson Brigid M, Garner Will, Beste Lauren A, Maier Marissa M, Ohl Michael E

Abstract excerpt

BACKGROUND: Cases of HIV, while infrequent, have been reported during tenofovir disoproxil fumarate/emtricitabine use as pre-exposure prophylaxis (PrEP). We describe the incidence of HIV and patterns of PrEP use within the Veterans Health Administration (VHA). METHODS: We conducted a retrospective cohort study among persons initiating PrEP in the VHA between July 2012 and April 2016 using national VHA data. We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenine
Share to Anti-HIV Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Combinations

Share to Drug Resistance, Viral

Share to Emtricitabine

Share to Incidence

Share to United States

Source

Identifiers

PMID: 31714421
DOI: 10.1097/QAI.0000000000002186

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Brief Report: Incidence of HIV in a Nationwide Cohort Receiving Pre-exposure Prophylaxis for HIV Prevention.PMID 31714421Read ↗

Pre-exposure Prophylaxis Use History in People With Antiretroviral Resistance at HIV Diagnosis: Findings From New York City HIV Surveillance and Partner Services, 2015-2022.Semantic proximity Read ↗

Oral Pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populationsSemantic proximity Read ↗

Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case reportSemantic proximity Read ↗

High incidence of HCV in HIV-negative men who have sex with men using pre-exposure prophylaxis.Semantic proximity Read ↗

Preexposure prophylaxis-selected drug resistance decays rapidly after drug cessationSemantic proximity Read ↗

Real-world HIV RNA and Antigen/Antibody Testing Among People Who Use Long-acting Injectable Preexposure ProphylaxisSemantic proximity Read ↗

Low retention on PrEP and barriers to PrEP use among key populations in Kinshasa, DRC: a mixed method studySemantic proximity Read ↗

Quantifying the number of people who would benefit from HIV pre-exposure prophylaxis (PrEP) in the United States: a comparison of behavioral, acquisition-risk based, and economic metricsSemantic proximity Read ↗

Adherence to quarterly HIV prevention services and its impact on HIV incidence in men who have sex with men in West Africa (CohMSM ANRS 12324 – Expertise France)Semantic proximity Read ↗

Pharmacokinetics, pharmacodynamics, efficacy and drug resistance selection of injectable long-acting lenacapavir pre-exposure prophylaxis (PrEP) against HIVSemantic proximity Read ↗

HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial.Semantic proximity Read ↗

Seroconversion on preexposure prophylaxis: a case report with segmental hair analysis for timed adherence determination.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.